Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilization

BACKGROUND: The safety and tolerability of a new highly purified, urine-derived human menopausal gonadotropin (hMG) preparation [Menopur(R)] was compared with a currently available hMG [Repronex (R)] in women undergoing in vitro fertilization (IVF). METHODS: This was a randomized, open-label, parall...

Descripción completa

Detalles Bibliográficos
Autores principales: Keye, William R, Webster, Bobby, Dickey, Richard, Somkuti, Stephen, Crain, Jack, Scobey, M Joseph
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1309620/
https://www.ncbi.nlm.nih.gov/pubmed/16280073
http://dx.doi.org/10.1186/1477-7827-3-62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1309620/
https://www.ncbi.nlm.nih.gov/pubmed/16280073
http://dx.doi.org/10.1186/1477-7827-3-62

Ejemplares similares